Determination of markers of ethyl alcohol consumption in pregnancy

Czech version

Authors: Maroš Boďa ¹; Andrej Chyba ² ; Jozef Záhumenský ¹ ; Petra Pšenková ¹
Authors‘ workplace: II. gynekologicko-pôrodnícka klinika LF UK a UN Bratislava, Slovenská republika ¹; Chemický ústav Slovenskej akadémie vied, Bratislava, Slovenská republika ²
Published in: Ceska Gynekol 2025; 90(5): 360-365
Category: Original Article
doi: https://doi.org/10.48095/cccg2025360

Overview

Prenatal alcohol exposure (PAE), with a global prevalence of approximately 10%, is the most common preventable cause of fetal morbidity, with fetal alcohol syndrome representing its most severe manifestation. The current gold standard for diagnosing PAE relies on self-reported questionnaires; however, underreporting remains a significant limitation. Consequently, there is a need for objective diagnostic methods. Among the most promising biomarkers are ethanol metabolites present in the first stool of newborns (meconium). In this preliminary study, we quantified ethyl glucuronide (EtG) and ethyl sulfate (EtS) in meconium samples and compared the results with self-reported PAE data from questionnaires. The study included 51 pregnant women. A meconium sample was collected from each newborn and analyzed using liquid chromatography-mass spectrometry. All participants were asked to complete a questionnaire regarding alcohol consumption during pregnancy. EtG was detected in 41 samples (80.3%) and EtS was present in all 51 samples (100%). Three of the 51 women did not complete the questionnaire. Of the remaining 48, six (11.7%) reported alcohol consumption during pregnancy. The median concentrations of EtG and EtS were 49.6 ng/g and 13.9 ng/g, respectively. Median levels of both biomarkers were higher among women who reported alcohol use compared to those who denied it. Notably, EtG concentrations exceeding 30 ng/g –⁠ previously suggested in the literature as a potential cut off for PAE –⁠ were found in 82.35% of women who reported no alcohol use. This study confirms that EtG and EtS are reliable markers of ethanol exposure in meconium. However, we were unable to determine definitive cut off values for PAE based on these biomarkers. Elevated EtG levels in women who denied alcohol consumption may be attributable to alternative sources of ethanol exposure or endogenous ethanol production. The possibility of underreporting PAE also cannot be ruled out.

Keywords:

biomarkers – meconium – Prenatal Alcohol Exposure – fetal alcohol syndrome

Sources

1. Popova S, Charness ME, Burd L et al. Fetal alcohol spectrum disorders. Nat Rev Dis Primer 2023; 9 (1): 11. doi: 10.1038/s41572-023-00420-x.

2. Dejong K, Olyaei A, Lo JO. Alcohol use in pregnancy. Clin Obstet Gynecol 2019; 62 (1): 142–155. doi: 10.1097/GRF.0000000000000414.

3. Hur YM, Choi J, Park S et al. Prenatal maternal alcohol exposure: diagnosis and prevention of fetal alcohol syndrome. Obstet Gynecol Sci 2022; 65 (5): 385–394. doi: 10.5468/ogs.22123.

4. Popova S, Lange S, Probst C et al. Estimation of national, regional, and global prevalence of alcohol use during pregnancy and fetal alcohol syndrome: a systematic review and meta-analysis. Lancet Glob Health 2017; 5 (3): e290–e299. doi: 10.1016/S2214-109X (17) 30021-9.

5. Wozniak JR, Riley EP, Charness ME. Clinical presentation, diagnosis, and management of fetal alcohol spectrum disorders. Lancet Neurol 2019; 18 (8): 760–770. doi: 10.1016/S1474-44 22 (19) 30150-4.

6. Lees B, Mewton L, Jacobus J et al. Association of prenatal alcohol exposure with psychological, behavioral, and neurodevelopmental outcomes in children from the adolescent brain cognitive development study. Am J Psychiatry 2020; 177 (11): 1060–1072. doi: 10.1176/appi.ajp.2020.20010086.

7. Dörrie N, Föcker M, Freunscht I et al. Fetal alcohol spectrum disorders. Eur Child Adolesc Psychiatry 2014; 23 (10): 863–875. doi: 10.1007/s00787-014-0571-6.

8. Mattson SN, Bernes GA, Doyle LR. Fetal alcohol spectrum disorders: a review of the neurobehavioral deficits associated with prenatal alcohol exposure. Alcohol Clin Exp Res 2019; 43 (6): 1046–1062. doi: 10.1111/acer.14040.

9. Jańczewska I, Wierzba J, Cichoń-Kotek M et al. Fetal alcohol spectrum disorders –⁠ diagnostic difficulties in the neonatal period and new diagnostic approaches. Dev Period Med 2019; 23 (1): 60–61. doi: 10.34763/devperiodmed.20192301.6066.

10. Jonsson E. Fetal alcohol spectrum disorders (FASD): a policy perspective. Can J Psychiatry 2019; 64 (3): 161–163. doi: 10.1177/0706743718 773706.

11. Jones AW. Brief history of the alcohol biomarkers CDT, EtG, EtS, 5-HTOL, and PEth. Drug Test Anal 2024; 16 (6): 570–587. doi: 10.1002/dta.3584.

12. Bager H, Christensen LP, Husby S et al. Biomarkers for the detection of prenatal alcohol exposure: a review. Alcohol Clin Exp Res 2017; 41 (2): 251–261. doi: 10.1111/acer.13309.

13. Morini L, Marchei E, Vagnarelli F et al. Ethyl glucuronide and ethyl sulfate in meconium and hair-potential biomarkers of intrauterine exposure to ethanol. Forensic Sci Int 2010; 196 (1–3): 74–77. doi: 10.1016/j.forsciint.2009.12.035.

14. Walsham NE, Sherwood RA. Ethyl glucuronide and ethyl sulfate. Adv Clin Chem 2014; 67 : 47–71. doi: 10.1016/bs.acc.2014.09.006.

15. Himes SK, Dukes KA, Tripp T et al. Clinical sensitivity and specificity of meconium fatty acid ethyl ester, ethyl glucuronide, and ethyl sulfate for detecting maternal drinking during pregnancy. Clin Chem 2015; 61 (3): 523–532. doi: 10.1373/clinchem.2014.233718.

16. Helander A, Olsson I, Dahl H. Postcollection synthesis of ethyl glucuronide by bacteria in urine may cause false identification of alcohol consumption. Clin Chem 2007; 53 (10): 1855–1857. doi: 10.1373/clinchem.2007.089482.

17. Costantino A, Digregorio EJ, Korn W et al. The effect of the use of mouthwash on ethylglucuronide concentrations in urine. J Anal Toxicol 2006; 30 (9): 659–662. doi: 10.1093/jat/30.9.659.

18. Thierauf A. Urine tested positive for ethyl glucuronide and ethyl sulphate after the consumption of “non-alcoholic” beer. Forensic Sci Int. 2010 [online]. Available from: https: //www.academia.edu/73715232/Urine_tested_positive_for_ethyl_glucuronide_and_ethyl_sulphate_after_the_consumption_of_non_alcoholic_ beer.

ORCID autorov

A. Chyba 0009-0008-3155-3739

J. Záhumenský 0000-0003-0475-6035

P. Pšenková 0000-0002-5706-9936

Doručené/Submitted: 27. 4. 2025

Prijaté/Accepted: 5. 8. 2025

MUDr. Maroš Boďa

II. Gynekologicko-pôrodnícka klinika

LF UK a UN Bratislava

Ružinovská 6

826 06 Bratislava

Slovenská republika